Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 0 (Neoplasm Proteins). Found 5 abstracts

Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. The Prostate. 2007 May;67(6):582-90.
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 2005 Jan;8(1):19-30.
Milling SW, Sai T, Silvers WK, Mintz B. Inhibition of melanoma growth after treatment with dendritic cells in a Tyr-SV40E murine model requires CD4+ T cells but not CD8+ T cells. Melanoma Research. 2004 Dec;14(6):555-62.
Balogh GA, Russo IH, Russo J. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells. International Journal of Oncology. 2003 Aug;23(2):411-9.
Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochemical pharmacology. 2002 Apr;63(7):1219-28.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 0 (Neoplasm Proteins)

Neoplasm Proteins 0 (Neoplasm Proteins) me [Metabolism] pa [Pathology] Amino Acid Sequence Phenotype mammalian) 0 (MLH1 protein human) EC 3-6-1 (PMS2 protein aa [Analogs & Derivatives] Non-US Gov't Research Support DNA-Binding Proteins pd [Pharmacology] 0 (DNA-Binding Proteins) de [Drug Effects] Adenosinetriphosphatase ph [Physiology] Antitumor Drug Screening Assays Mice EC 6-5-1 (DNA Repair Enzymes) EC 3-6-1-3 (Adenosinetriphosphatase) Cell Cycle Comparative Study DNA Repair Enzymes ge [Genetics] Macrophages Transgenic Mice Histones Paclitaxel Guanine ras Proteins Reverse Transcriptase Polymerase Chain Reaction Cell Count 0 (Immunoglobulin G) human) 0 (ASF1A protein Cultured Cells dt [Drug Therapy] Experimental Melanoma Neoplasm RNA Neoplasm Metastasis Transformed Cell Line Simian virus 40 0 (Recombinant Fusion Proteins) Inbred C57BL Mice 0 (Indoles) Molecular Sequence Data Immunoprecipitation Male Immunoglobulin G Genetic Polymorphism 1406-18-4 (Vitamin E) Cell Survival 0 (Transcription Factors) Heterochromatin Cell Cycle Proteins 73-40-5 (Guanine) human) 0 (PMS1 protein 107283-02-3 (heterochromatin-specific nonhistone chromosomal Monophenol Monooxygenase 0 (Cell Cycle Proteins) Immunologic Cytotoxicity Tests Phytogenic Antineoplastic Agents Cultured Tumor Cells 0 (Transcription Factor AP-1) 0 (Histones) Antineoplastic Agents Amino Acid Sequence Homology Phytogenic) 0 (Antineoplastic Agents 0 (Proto-Oncogene Proteins c-bcl-2) Biological) 0 (Tumor Markers 17407-37-3 (vitamin E succinate) human) 143220-95-5 (PML protein mt [Methods] 0 (NF-kappa B) SCID Mice 0 (Heterochromatin) Proto-Oncogene Proteins Alkylating Antineoplastic Agents Transfection Non-Histone) 0 (Chromosomal Proteins EC 1-14-18-1 (Monophenol Monooxygenase) 0 (cyclin-dependent kinase Inhibitor p21) Dendritic Cells EC 2-1-1-63 (O(6)-Methylguanine-DNA Methyltransferase) Mutation 85622-93-1 (temozolomide) Cytokines Glioma O(6)-Methylguanine-DNA Methyltransferase Nuclear Proteins Alkylating) 0 (Antineoplastic Agents 0 (Cyclins) 0 (Nuclear Proteins) 0 (Repressor Proteins) bl [Blood] th [Therapy] Neoplasm) 0 (RNA Multiple Drug Resistance Drug Dose-Response Relationship Skin Neoplasms im [Immunology] Non-Histone Chromosomal Proteins 0 (Proto-Oncogene Proteins) Protein p53 Repressor Proteins Gene Expression Regulation Western Blotting CD4-Positive T-Lymphocytes du [Diagnostic Use] Transcription Factor AP-1 0 (Peptide Fragments) 0 (Cytokines) mammalian) 0 (MSH2 protein Tumor-Infiltrating Lymphocytes Epithelial Cells EC 3-6-1 (ras Proteins) Cytotoxic T-Lymphocytes Vitamin E 33069-62-4 (Paclitaxel) 23214-92-8 (Doxorubicin) Recombinant Fusion Proteins 4342-03-4 (Dacarbazine) Peptide Fragments Breast Neoplasms NF-kappa B DNA Repair CD8-Positive T-Lymphocytes 0 (Melan-A protein) Dosage Compensation (Genetics) Cell Line 0 (macroH2A histone) Cyclins protein HP-1) Doxorubicin Cell Aging Neoplasm Invasiveness Biological Tumor Markers 19916-73-5 (O(6)-benzylguanine) 47165-04-8 (dapi) 0 (Protein p53) 0 (Antineoplastic Agents) Neoplastic Cell Transformation Transcription Factors Cell Proliferation Immunohistochemistry Dacarbazine Messenger) 0 (RNA ai [Antagonists & Inhibitors] 0 (G-T mismatch-binding protein) bi [Biosynthesis] Indoles
Last updated on Tuesday, August 11, 2020